Abstract:Objective: To determine how dysfunctional astrocyte glutamate transporters contribute to microglial pruning of glutamatergic synapses and memory deficiency in Alzheimer’s disease (AD). Background: Astrocytes are the most abundant and heterogeneous type of glial cells in the brain, we tested the hypothesis that amyloid fibrils impair astrocyte glutamate transporters, thus leading to an abnormal accumulation of extrasynaptic glutamate, which in turn contributes to microglial pruning of glutamatergic synapses and memory deficiency in the rodent models of AD. Design/Methods: Aβ1–40 fibrils were microinjected bilaterally into hippocampal CA1 areas in rats. In another cohorts, DL-threo-beta-benzyloxyaspartate (DL-TBOA), a specific inhibitor of glutamate transporter 1 (GLT1), or ceftriaxone (used to enhance GLT1 function) were also microinjected into hippocampal CA1 areas. Immunostaining and immunoblotting were performed to detect the expression of GLT1 in astrocytes. Complement C1q production and microglial pruning of glutamatergic synapses were assessed by 3D immunofluorescence imaging. Morris water maze test was performed to evaluate the cognitive function. Results: A significant GLT1 reduction in the hippocampal astrocytes in rats injected with amyloid fibrils, indicating dysfunctional glutamate uptake. Microinjection of ceftriaxone significantly attenuated C1q expression and endocytosis of vGluT1 within microglia, and improved behavioral performance in the modeled rats. These results suggested that upregulation of GluT1 expression restored the synaptic microglial pruning and cognition impaired by amyloid fibrils. Meanwhile, in naive rats, microinjection of DL-TBOA substantially increased C1q expression, increased localization of vGluT1 within microglia, and impaired performance in the Morris water maze. This suggests that dysfunctional GluT1, which likely leads to extracellular accumulation of glutamate, contributes to C1q-mediated microglial pruning of synapses and cognitive deficits induced by amyloid fibrils. Conclusions: Reduction of astrocytic GLT1 contributes to C1q production and microglial pruning of glutamatergic synapses, hippocampal synaptic dysfunction and memory deficit in the AD model. Disclosure: Dr. Wu has nothing to disclose. Dr. Bie has nothing to disclose. Dr. Naguib has nothing to disclose.

Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency

Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.

NFκB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease.

Anti -mouse CX3CR1 Antibody Alleviates Cognitive Impairment, Neuronal Loss and Myelin Deficits in an Animal Model of Brain Ischemia

CCR5 regulates Aβ1-42-induced learning and memory deficits in mice

Reduction of Astrocytic Glutamate Transporter Contributes to Amyloid-induced phagocytosis

Fractalkine (CX3CL1) and Brain Inflammation: Implications for HIV-1-Associated Dementia

Suppressed Pro-Inflammatory Response of Microglia in CX3CR1 Knockout Mice

Decreased Fractalkine and Increased IP-10 Expression in Aged Brain of APP swe Transgenic Mice

Xanthoceraside attenuates amyloid β peptide1-42-induced memory impairments by reducing neuroinflammatory responses in mice

Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer’s Disease

Activation of the Cb2 Receptor System Reverses Amyloid-Induced Memory Deficiency

CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke

Microglia CREB-Phosphorylation Mediates Amyloid-β-Induced Neuronal Toxicity.

The chemokine-like receptor 1 deficiency improves cognitive deficits of AD mice and attenuates tau hyperphosphorylation via regulating tau seeding.

VEGF-A in serum protects against memory impairment in APP/PS1 transgenic mice by blocking neutrophil infiltration

Epigenetic Suppression of Hippocampal BDNF Mediates the Memory Deficiency Induced by Amyloid Fibrils

Complement C3aR Depletion Reverses HIF-1-induced Metabolic Impairment and Enhances Microglial Response to A Pathology

Epigenetic suppression of neuroligin 1 underlies amyloid-induced memory deficiency

Concerted Cellular Responses to Type I Interferon Propel Memory Impairment Associated with Amyloid Β Plaques

Activation of Α7 Nicotinic Acetylcholine Receptor Alleviates Aβ1-42-induced Neurotoxicity Via Downregulation of P38 and JNK MAPK Signaling Pathways.